Key result
Anticoagulant therapy with a vitamin K antagonist completely resolved post-TAVI bioprosthetic valve thrombosis and normalized transvalvular gradients in an 82-year-old patient.
Case Report (n=1)
Anticoagulant therapy with vitamin K antagonists can effectively treat early bioprosthetic valve thrombosis following TAVI, restoring normal valve hemodynamics.
Supports VKA consideration for post-TAVI thrombosis; hypothesis-generating and should not yet change practice.
Bioprosthetic thromboses are rarely reported in post-transcatheter aortic valve implantation (TAVI). We describe herein the case of bioprosthetic valve thrombosis in an 82-year-old patient which resolved completely after anticoagulant therapy.
No takes yet. Share an insight, caveat, or question.
Descoux et al. (2015) conducted a case report in Post-TAVI bioprosthetic thrombosis (n=1). Anticoagulant therapy (Vitamin K Antagonist) was evaluated on Resolution of bioprosthetic thrombosis and improvement in echocardiographic parameters. Anticoagulant therapy with a vitamin K antagonist completely resolved post-TAVI bioprosthetic valve thrombosis and normalized transvalvular gradients in an 82-year-old patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: